EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3177-3182

  Rodrigo, Juan P ^a,b   García, Luis A ^a   Ramos, Sofía ^a   Lazo, Pedro S ^a   Suárez, Carlos ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; HEAD CANCER; HUMAN; HUMAN TISSUE; MALE; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; CORTACTIN; CYCLIN D1; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0033870355     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Merritt, W. D., Weissler, M. C., Turk, B. F., and Gilmer, T. M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 116: 1394-1398, 1990.
2. Leonard, J. H., Kearsley, J. H., Chenevix-Trench, G. E., and Hayward, N. K. Analysis of gene amplification in head and neck squamous cell carcinomas. Int. J. Cancer, 48: 511-515, 1991.
3. Williams, M. E., Gaffey, M. J., Weiss, L. M., Wilczynski, S. P., Schuuring, E., and Levine, P. A. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 119: 1238-1243, 1993.
4. Callender, T., El-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
5. Fortin, A., Guerry, M., Guerry, R., Talbot, M., Parise, O., Schwaab, G., Bosq, J., Bourhis, J., Salvatori, P., Janot, F., and Busson, P. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence. Clin. Cancer Res., 3: 1609-1614, 1997.
6. Akervall, J. A., Michalides, R. J. A. M., Mineta, H., Balm, A., Borg, A., Dictor, M. R., Jin, Y., Loftus, B., Mertens, F., and Wennerberg, J. P. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila.), 79: 380-389, 1997.
7. Alavi, S., Namazie, A., Calcaterra, T. C., Wang, M. B., and Srivatsan, E. S. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer. Laryngoscope, 109: 874-879, 1999.
8. Schuuring, E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene (Amst.), 159: 83-96, 1995.
9. Meredith, S. D., Levine, P. A., Burns, J. A., Gaffey, M. J., Boyd, J. C., Weiss, L. M., Erickson, N. L., and Williams, M. E. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch. Otolaryngol. Head Neck Surg., 121: 790-794, 1995.
10. Muller, D., Millon, R., Liderau, R., Engelmann, A., Bronner, G., Eber, M., Methlin, G., and Abecassis, J. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer B Oral Oncol., 30B: 113-120, 1994.
11. Muller, D., Millon, R., Velten, M., Bronner, G., Jung, G., Engelmann, A., Flesch, H., Eber, M., Methlin, G., and Abecassis, J. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur. J. Cancer, 33A: 2203-2210, 1997.
12. Takes, R. P., Baatenburg de Jong, R. J., Schuuring, E., Hermans, J., Vis, A. A., Litvinov, S., and van Krieken, J. H. J. M. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch. Otolaryngol. Head Neck Surg., 123: 412-419, 1997.
13. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Taraserra, J., and Cardesa, A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
14. Michalides, R., Van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
15. Michalides, R. J. A. M., van Veelen, N. M. J., Kristel, P. M. P., Hart, A. A. M., Loftus, B. M., Hilgers, F. J. M., and Balm, A. J. M. Overexpression of cyclin D1 indicated a poor prognosis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 479-502, 1997.
16. Bova, R. J., Quinn, D. I., Nankervis, J. S., Cole, I. E., Sheridan, B. F., Jensen, M. J., Morgan, G. J., Hughes, C. J., and Sutherland, R. L. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin. Cancer Res., 5: 2810-2819, 1999.
17. Nogueira, C. P., Dolan, R. W., Gooey, J., Byahatti, S., Vaughn, C. W., Fuleihan, N. S., Grillona, G., Baker, E., and Domanowski, G. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope, 108: 345-350, 1998.
18. Patel, A. S., Schechter, G. L., Wasilenko, W. J., and Somers, K. D. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene, 16: 3227-3232, 1998.
19. Rodrigo, J. P., Ramos, S., Lazo, P. S., Alvarez, I., and Suárez, C. Amplification of ERBB oncogenes in squamous cell carcinomas of the head and neck. Eur. J. Cancer, 32A: 2004-2010, 1996.
20. Frye, R. A., Benz, C. C., and Liu, E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene, 4: 1153-1157, 1989.
21. Schereiber, G., and Dubeau, L. c-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am. J. Pathol., 137: 653-658, 1990.
22. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
23. Peto, R., Pike, M. C., Armitage, P. E., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., MacPherson, K., Peto, J., and Smith, P. G. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br. J. Cancer, 34: 585-612, 1976.
24. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B, 34: 187-210, 1972.
25. 1. Genes Dev., 7: 812-821, 1993.
26. Schuuring, E., Verhoeven, E., Litvinov, S., and Michalides, R. J. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol. Cell. Biol., 13: 2891-2898, 1993.
27. Karlseder, J., Zeillinger, R., Schneeberger, C., Czerwenka, K., Speiser, P., Kubista, E., Birnbaum, D., Gaudray, P., and Theillet, C. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer, 9: 42-48, 1994.
28. Gleich, L. L., Li, Y. Q., Wang, X., Stambrook, P., and Gluckman, J. L. Variable genetic alterations and survival in head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 125: 949-952, 1999.